Why Nostr? What is Njump?
2025-01-13 19:32:18

halama_immuno on Nostr: Small but very interesting: a new personalized T cell therapy in advanced metastatic ...

Small but very interesting: a new personalized T cell therapy in advanced metastatic #melanoma. Feasibility is demonstrated for this new #immunotherapy, but production time is
still around 19 weeks. Disease stabilisation is observed and immune responses could be measured.
#Oncology #Immunology #science #health

https://www.nature.com/articles/s41591-024-03418-4

Author Public Key
npub18j3k3qhncrka7sq64g4cnkl86rr278sqae88nfxnpk6zrggr347qh0f0p9